Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2018

Open Access 01-12-2018 | Research article

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation

Authors: Hongwei Tian, Jingang Cui, Chengzhi Yang, Fenghuan Hu, Jiansong Yuan, Shengwen Liu, Weixian Yang, Xiaowei Jiang, Shubin Qiao

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Login to get access

Abstract

Background

Atrial fibrillation (AF) is the most common complication in hypertrophic cardiomyopathy (HCM). The mechanisms of AF is associated with left atrial (LA) structural remodeling in HCM patients. However, the impact of left ventricular (LV) remodeling on the presence of AF in HCM patients has not been evaluated yet. We sought to investigate effect of LV remodeling on the presence of AF assessed by cardiovascular magnetic resonance (CMR) in HCM patients.

Methods

A total of 394 HCM patients were enrolled into this study, including HOCM patients (n = 293) and NOHCM patients (n = 101). Patients were divided into HCM with AF (50) and HCM without AF (n = 344). Data were collected from hospital records.

Results

LA diameter and LV remodeling index (LVRI) were significantly higher in HCM patients with AF than that of HCM patients without AF (46.6 ± 7.4 mm versus 39.9 ± 8.0 mm, p < 0.001, and 1.46 ± 0.6 versus 1.2 ± 0.4, p = 0.002, respectively). HCM patients with AF were older than HCM patients without AF (53.6 ± 11.7 years versus 47.7 ± 13.6 years, p = 0.002). Additionally, LVRI positively correlated to LA size (r = 0.12, p = 0.02). In a multivariable logistic regression analysis, when adjusting for age and LV end diastolic mass index, LVRI and LA size remained an independent determinant of AF in HCM patients (OR = 4.7, p = 0.001 and OR = 1.13, P < 0.001).

Conclusion

HCM patients with AF showed significantly more LA diameter, LVRI and age than HCM patients without AF. LVRI and LA size were strong independent predictor of AF in HCM, suggesting LV remodeling may contribute to the occurrence of AF in HCM patients.
Literature
1.
go back to reference Maron BJ. Hypertrophic cardiomyopathy: a systematic review. Jama. 2002;287(10):1308–20.CrossRef Maron BJ. Hypertrophic cardiomyopathy: a systematic review. Jama. 2002;287(10):1308–20.CrossRef
2.
go back to reference Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, et al. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Cardiovasc Magn Reson. 2009;11(1):1–9.CrossRef Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, et al. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Cardiovasc Magn Reson. 2009;11(1):1–9.CrossRef
3.
go back to reference Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517–24.CrossRef Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517–24.CrossRef
4.
go back to reference Doi Y, Kitaoka H. Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation. J Cardiol. 2001;37(Suppl 1):133.PubMed Doi Y, Kitaoka H. Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation. J Cardiol. 2001;37(Suppl 1):133.PubMed
5.
go back to reference Dzeshka MS, Lip GYH, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943–59.CrossRef Dzeshka MS, Lip GYH, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943–59.CrossRef
6.
go back to reference De-Castro S, Caselli SM, Pelliccia A, Cavarretta E, Maddukuri P, Cartoni D, et al. Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart. 2007;93(2):205–9.CrossRef De-Castro S, Caselli SM, Pelliccia A, Cavarretta E, Maddukuri P, Cartoni D, et al. Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart. 2007;93(2):205–9.CrossRef
7.
go back to reference Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2002;11(3):58. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2002;11(3):58.
8.
go back to reference Yamaji K, Fujimoto S, Yutani C, Ikeda Y, Mizuno R, Hashimoto T, et al. Does the progression of myocardial fibrosis lead to atrial fibrillation in patients with hypertrophic cardiomyopathy? Cardiovasc Pathol. 2001;10(6):297.CrossRef Yamaji K, Fujimoto S, Yutani C, Ikeda Y, Mizuno R, Hashimoto T, et al. Does the progression of myocardial fibrosis lead to atrial fibrillation in patients with hypertrophic cardiomyopathy? Cardiovasc Pathol. 2001;10(6):297.CrossRef
9.
go back to reference Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006;113(14):1807–16.CrossRef Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006;113(14):1807–16.CrossRef
10.
go back to reference Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–6.CrossRef Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–6.CrossRef
11.
go back to reference Schulzmenger J, Abdelaty H, Busjahn A, Wassmuth R, Pilz B, Dietz R, et al. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2006;8(5):741–6.CrossRef Schulzmenger J, Abdelaty H, Busjahn A, Wassmuth R, Pilz B, Dietz R, et al. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2006;8(5):741–6.CrossRef
12.
go back to reference Schulzmenger J, Abdelaty H, Rudolph A, Elgeti T, Messroghli D, Utz W, et al. Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance. Eur J Heart Fail. 2008;10(9):850–4.CrossRef Schulzmenger J, Abdelaty H, Rudolph A, Elgeti T, Messroghli D, Utz W, et al. Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance. Eur J Heart Fail. 2008;10(9):850–4.CrossRef
13.
go back to reference Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc. 2014;3(3):e001002.CrossRef Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc. 2014;3(3):e001002.CrossRef
14.
go back to reference Manuguerra R, Callegari S, Corradi D. Inherited structural heart diseases with potential atrial fibrillation occurrence. J Cardiovasc Electrophysiol. 2015;27(2):242–52.CrossRef Manuguerra R, Callegari S, Corradi D. Inherited structural heart diseases with potential atrial fibrillation occurrence. J Cardiovasc Electrophysiol. 2015;27(2):242–52.CrossRef
15.
go back to reference Losi MA, Betocchi S, Aversa M, Lombardi R, Miranda M, D’Alessandro G, et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2004;94(7):895–900.CrossRef Losi MA, Betocchi S, Aversa M, Lombardi R, Miranda M, D’Alessandro G, et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2004;94(7):895–900.CrossRef
16.
go back to reference Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005;18(10):1074–82.CrossRef Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005;18(10):1074–82.CrossRef
17.
go back to reference Barbero U, Destefanis P. An Indian-look right into restrictive cardiomyopathies. Indian Heart J. 2015;67(6):512–3.CrossRef Barbero U, Destefanis P. An Indian-look right into restrictive cardiomyopathies. Indian Heart J. 2015;67(6):512–3.CrossRef
18.
go back to reference Poliac LC, Barron ME, Maron BJ. Hypertrophic cardiomyopathy | anesthesiology | ASA publications. Anesthesiology. 2006;104(1):183.CrossRef Poliac LC, Barron ME, Maron BJ. Hypertrophic cardiomyopathy | anesthesiology | ASA publications. Anesthesiology. 2006;104(1):183.CrossRef
19.
go back to reference Camici PG, Olivotto I, Rimoldi OE. The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol. 2012;52(4):857–64.CrossRef Camici PG, Olivotto I, Rimoldi OE. The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol. 2012;52(4):857–64.CrossRef
20.
go back to reference Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M. Hypertrophic cardiomyopathy: a review. Anesth Analg. 2015;120(3):554–69.CrossRef Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M. Hypertrophic cardiomyopathy: a review. Anesth Analg. 2015;120(3):554–69.CrossRef
21.
go back to reference Barbero U, Ho SY. Anatomy of the atria: A road map to the left atrial appendage. Herzschrittmacherther Elektrophysiol. 2017;28(4):347–54.CrossRef Barbero U, Ho SY. Anatomy of the atria: A road map to the left atrial appendage. Herzschrittmacherther Elektrophysiol. 2017;28(4):347–54.CrossRef
22.
go back to reference Ozdemir O, Soylu M, Demir AD, Topaloglu S, Alyan O, Turhan H, et al. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2004;94(2–3):163–6.CrossRef Ozdemir O, Soylu M, Demir AD, Topaloglu S, Alyan O, Turhan H, et al. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2004;94(2–3):163–6.CrossRef
23.
go back to reference Liu T, Li G. Potential mechanisms between atrial dilatation and atrial fibrillation. Am Heart J. 2006;151(2):e1.CrossRef Liu T, Li G. Potential mechanisms between atrial dilatation and atrial fibrillation. Am Heart J. 2006;151(2):e1.CrossRef
Metadata
Title
Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
Authors
Hongwei Tian
Jingang Cui
Chengzhi Yang
Fenghuan Hu
Jiansong Yuan
Shengwen Liu
Weixian Yang
Xiaowei Jiang
Shubin Qiao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-018-0945-7

Other articles of this Issue 1/2018

BMC Cardiovascular Disorders 1/2018 Go to the issue